靶向PD⁃L1分子的 RNAi增强树突状细胞疫苗对胰腺癌治疗作 用的实验研究
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81302146);中国博士后基金(2016M591913);江苏省青年医学人才(QNRC2016732);江苏省 自然科学基金(BK20161225);江苏省卫生计生委科研课题(H201620);苏州市科技计划(SYS201539)


RNAi targeting PD⁃L1 enhances DC vaccination antitumor immunologic therateupic effect against pancreatic cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:研究通过 RNA干扰敲减程序性死亡受体配体 1(programmed death receptor ligand 1,PD-L1)分子能否增强树 突状细胞疫苗对胰腺癌的治疗作用。方法:免疫组化法检测42例胰腺癌及对应胰腺组织中PD-L1的表达差异;纯化CD8+T细 胞和制备成熟的树突状细胞(DC),将低表达PD-L1的Panc-1细胞Panc-1/PD-L1-RNAi、阴性对照Panc-1/LV-Control细胞以及野 生型Panc-1细胞分别与CD8+T细胞+DC疫苗共同培养,检测细胞上清中干扰素(IFN)-γ表达水平;3组肿瘤细胞分别建立人源 化严重免疫缺陷(severe combined immunodeficiency,SCID)小鼠胰腺癌皮下移植瘤模型,以 DC疫苗为治疗手段进行尾静脉注 射,观察肿瘤生长情况。结果:免疫组化实验显示,胰腺癌组织较胰腺组织中PD-L1高表达,差异有统计学意义(P<0.001)。T 细胞反应实验显示,PD-L1敲减肿瘤细胞组与DC和CD8+T细胞共同培养的上清中IFN-γ表达水平明显高于其他2个对照组,差 异有统计学意义(P<0.001)。人源化SCID小鼠体内荷瘤实验显示,敲减PD-L1表达与应用DC疫苗治疗胰腺癌皮下移植瘤具 有协同作用。结论:胰腺癌较胰腺组织中PD-L1高表达,敲减胰腺癌细胞PD-L1表达与应用DC疫苗治疗可能是胰腺癌免疫治 疗的有效策略。

    Abstract:

    Objective:To investigate whether knocking down PD - L1 expression can enhance the effects of DC vaccine to treat pancreatic cancer. Methods:PD-L1 expression in normal pancreatic tissues and pancreatic cancer tissue specimens were detected by immunohistochemistry in tumor specimen of 42 pancreatic carcinoma patients respectively. A Panc-1 cell line with low PD-L1 expression established by lentivirus mediated RNA interference targeting PD-L1 was named Panc- 1/PD-L1- RNAi. At the same time,negative control cells Panc-1/LV-Control and wide type Panc-1 cell line was used in this study. These three groups of pancreatic cancer cells were co-cultured with CD8+ T cells and mature DC,and then IFN-γ production was detected by ELISA. Pancreatic cancer tumor-bearing hu- SCID mice model was established. DC vaccination was performed to investigate tumor inhibition effects. Results:Higher expressions of PD - L1 were detected in pancreatic carcinoma than in normal pancreatic tissue(P<0.001)detected by immunohistochemistry examination. In the T cell reaction study,IFN-γ production is much higher in the PD-L1 knocking down group than that in the other two control groups(P<0.001). In vivo,PD-L1 knocking down combined with DC vaccination could significantly prevent tumor growth in the hu-SCID model. Conclusion:PD-L1 is expressed higher in pancreatic cancer than in normal pancreatic tissue. Suppressing PD-L1 expression in cancer cells during DC vaccination might be a more efficient strategy in immunotherapy for pancreatic cancer

    参考文献
    相似文献
    引证文献
引用本文

蒋浩海,赵 鑫,赵 华,朱新国,李德春.靶向PD⁃L1分子的 RNAi增强树突状细胞疫苗对胰腺癌治疗作 用的实验研究[J].南京医科大学学报(自然科学版),2018,(1):40-43,79

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-10-31
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-02-02
  • 出版日期: